/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sara Carmen

AstraZeneca (Singapore)(SG)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

8

Papers

863

Citations

5

h-index

5

i10-index

Sara Carmen is an academic researcher from AstraZeneca (Singapore). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & IL-33, ST2, and ILC Pathways & Eosinophilic Esophagitis. The author has an h-index of 5, co-authored 7 publications.

Research Topics

Monoclonal and Polyclonal Antibodies Research IL-33, ST2, and ILC Pathways Eosinophilic Esophagitis Nanofabrication and Lithography Techniques T-cell and B-cell Immunology

Papers by this author

works

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

2023 · Scientific Reports · 89 citations

https://doi.org/10.1038/s41598-023-36642-y

Elizabeth England D. Gareth Rees Ian C. Scott Sara Carmen

Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library

2025 · SLAS DISCOVERY · 0 citations

https://doi.org/10.1016/j.slasd.2025.100216

Stacey E. Chin Pablo Gallego Anna Aagaard Sara Carmen

Research topics

topics

Monoclonal and Polyclonal Antibodies Research

IL-33, ST2, and ILC Pathways

Eosinophilic Esophagitis

Nanofabrication and Lithography Techniques

T-cell and B-cell Immunology

Chat about Author

Papers

Chat

Click to start Chat